innovrsrch（IRA） 产品代理
innovrsrch（IRA） 产品代理
三分之一个世纪以来，美国创新研究中心在改进定时释放技术方面一直处于领先地位。主要任务是规范给药技术。我们经过验证的缓释激素和药物丸剂可帮助研究人员负责产品交付并扩大他们进行有意义和可重复研究的能力。
研究问题
由于向研究动物口服给药药物和激素并不容易，因此已经设计了几种给药方法作为替代方案。然而，大多数科学家继续使用不可靠的注射剂进行研究。
由于这种不足，生物医学研究既具有挑战性又令人困惑，但又具有创造性。科学家解决科学问题的选择不仅取决于，而且还受到主动产品交付过程的限制。传统上，将产品输送到实验动物中一直是最易受变量影响且最难有效标准化的过程。必须准确地向实验动物给药的过程可能成为科学家的后勤噩梦。
研究解决方案：改变药物输送的时间进程
好消息是时代变了。我们经过验证的给药技术正在帮助研究人员消除对不可靠、间歇性注射的需求。自 1980 年以来，Innovative Research of America 一直是为科学家提供嵌入活性产品的长期连续释放药丸的领导者。我们的技术利用我们的基质驱动输送 (MDD) 颗粒系统，以可立即植入的形式提供成品。颗粒旨在，但不限于，简单的皮下植入实验动物。
(MDD) Pellet System 的独特工程整合了扩散、侵蚀和浓度梯度三个原理。它生成具有可生物降解基质的成品颗粒，可有效且持续地在动物体内释放活性产品。
颗粒输送系统可以帮助研究者负责标准化和再现研究结果。它有助于克服使用传统递送方法的研究人员经常遇到的问题。
Hormone and Drug Pellets For Biomedical Research
For a third of a century, Innovative Research of America has assumed the leadership role in improved time release technology. The main mission is to standardize the technology of drug delivery. Our proven Time Release Hormone and Drug Pellets help investigators take charge of product delivery and expand their abilities to do meaningful and reproducible research.
The Research Problem
Since it is not easy to administer drugs and hormones orally to research animals, several delivery methods have been devised as alternatives. However, most scientists continue to labor with unreliable injectables to conduct their research.
Because of this inadequacy, biomedical research is as confusing as it is challenging and as frustrating as it is creative. The options of scientists to address scientific questions are not only dependent, but are also limited by the process of active product delivery. Traditionally, product delivery into the experimental animal has been the procedure most subject to variables and the most difficult to standardize effectively. The very process of having to accurately administer drugs to experimental animals can become a logistic nightmare for scientists.
The Research Solution: Changing The Time Course Of Drug Delivery
The good news is that times have changed. Our proven Drug Delivery Technology is helping investigators eliminate the need for unreliable, intermittent injections. Since 1980, Innovative Research of America has been the leader in supplying scientists with long term continuous release pellets embedded with active products. Our technology provides finished products, in a ready-to-implant form, utilizing our Matrix-Driven Delivery (MDD) Pellet System. The pellets are intended for, although
not limited to, simple subcutaneous implantation in laboratory animals.
The unique engineering of the (MDD) Pellet System integrates the three principles of diffusion, erosion and concentration gradients. It generates a finished pellet with a biodegradable matrix that effectively and continuously releases the active product in the animal.
The pellet delivery system can help the investigator take charge of standardizing and reproducing research results. It helps overcome problems commonly encountered by researchers who employ conventional delivery methods.
